Quantification of cross-vendor variation in ADC measurements in vendor-specific prostate MRI-protocols.

The variation of ADC between different MRI systems and prostate specific DWI sequences is limited in this phantom study and without apparent clinical relevance. However, prospective multicenter studies of prostate cancer patients are needed for further investigation.